---
title: "Weekly BCI roundup — Week of 2026-02-14"
pubDate: 2026-02-14
description: "Early February’s strongest implantable-BCI signals were clinical repeatability and design-for-chronicity: second-in-human execution, insertion mechanics, and flexible-material evidence."
tags: ["BCI", "weekly", "implantable", "CorTec", "FDA", "materials", "preprints"]
links:
  - title: "CorTec announces successful second human implantation of Brain Interchange"
    url: "https://cortec-neuro.com/successful-second-human-implantation-bci-system/"
    note: "Company announcement (Feb 10, 2026): second implantation in an FDA IDE stroke study at Harborview/UW Medicine."
  - title: "FDA Quality Management System Regulation (QMSR) final rule"
    url: "https://www.federalregister.gov/documents/2024/02/02/2024-01711/medical-devices-quality-system-regulation-amendments"
    note: "Regulatory context: QMSR effective Feb 2, 2026."
  - title: "A Surgical Planning Pipeline for Human Implantable Brain-Computer Interfaces"
    url: "https://www.medrxiv.org/content/10.64898/2026.02.01.26345325v1.full.pdf"
    note: "medRxiv preprint (posted Feb 3, 2026): workflow standardization for planning and localization."
  - title: "Friend, not Foe: Lowered Tissue Reactivity to Long-Term Polyimide Implants"
    url: "https://www.biorxiv.org/content/10.64898/2026.02.06.703281v1"
    note: "bioRxiv preprint (Feb 9 window): flexible polyimide vs stiff silicon, with lower lesion/reactivity signals for polyimide."
  - title: "Multi-Layer Brain-Mimicking Phantom for Replicating Dura and Pia Membrane Dimpling and Rupture Properties"
    url: "https://www.biorxiv.org/content/10.64898/2026.02.05.704082v1"
    note: "bioRxiv preprint: tunable benchtop insertion-mechanics model (agarose + pre-stretched PVC dura analog)."
  - title: "Polymer-based flexible multi-shank probes for simultaneous intracortical microstimulation and two-photon calcium imaging"
    url: "https://www.biorxiv.org/content/10.64898/2026.02.09.704741v1"
    note: "bioRxiv preprint: flexible multi-shank stimulation with current-steering directionality gains."
  - title: "ONWARD enrolls first participant in Empower BP pivotal study (ARC-IM)"
    url: "https://www.globenewswire.com/news-release/2026/02/04/3231754/0/en/ONWARD-Medical-Announces-First-Participant-Enrolled-in-Global-Pivotal-Study-Evaluating-ARC-IM-System-to-Address-Blood-Pressure-Instability-After-Spinal-Cord-Injury.html"
    note: "Adjacent implantable-neurotech signal for clinical and regulatory execution infrastructure."
draft: false
---

Here’s what moved in *implantable BCIs* during *Feb 1–14, 2026*.

The most meaningful updates were not flashy demos. They were:
- clinical repeatability in humans, and
- design science that isolates what drives chronic failure (especially mechanics + material mismatch).

### 1) CorTec: second-in-human is a real milestone

CorTec reported a second successful implantation of its Brain Interchange platform in an FDA IDE stroke study at Harborview/UW Medicine.

That matters because many programs can do a first case; fewer can show repeatable workflow across additional participants. “Second-in-human” is often where teams prove the procedure can be operationalized, not just demonstrated.

### 2) Regulation is tightening around execution quality

FDA’s QMSR effective date (Feb 2, 2026) reinforces a broader trend: implantable, connected systems are expected to show mature quality systems and lifecycle discipline early, not after scale.

For implantable BCIs, this raises the floor for design controls, verification/validation traceability, and post-market readiness.

### 3) Preprints converged on one message: mechanics dominate chronic outcomes

Three early-February preprints point in the same direction:

- **Polyimide vs silicon chronic response:** flexible polyimide showed lower tissue reactivity/lesion burden than stiff silicon in long-term settings.
- **Insertion mechanics phantom:** a layered brain-mimicking phantom reproduced dimpling/rupture characteristics with lower variance, supporting faster bench screening before animal runs.
- **Flexible multi-shank stimulation:** polymer probes paired microstimulation with two-photon imaging and showed better spatial control using bipolar/current-steering paradigms.

Taken together, these are practical signals for implant design priorities: reduce mismatch, control insertion injury, and shape electric fields more selectively.

### 4) Adjacent signal: clinical infrastructure is expanding beyond cortical implants

ONWARD’s first participant in a pivotal ARC-IM study is not a brain implant milestone directly, but it reflects a useful ecosystem pattern: implantable neurotech teams are getting better at multicenter clinical execution and regulatory cadence.

That infrastructure tends to transfer across adjacent neuromodulation/BCI programs.

### Thread that ties the week together

Early February 2026 looked like an “engineering maturity” window for implantable BCIs:
- more repeatable human execution,
- more controlled evidence on chronic design choices,
- and stronger regulatory/process expectations around how these systems are built and maintained.

That is exactly the substrate the field needs before headline-grabbing capabilities can matter at scale.
